They company has stated that dosing events are no longer material. I think big pharma has simply told them that reporting on individual patients is not the way to go.
The information void will soon be over, but it should never have go this point. It has been terribly clumsy and unnecessary and should have been handled far better.
BLT Price at posting:
34.5¢ Sentiment: None Disclosure: Held